In cell analysis, real-time cell measurements provide a clear window into the critical functions driving cell signalling, proliferation, activation, toxicity and biosynthesis.
In this webinar, Dr. George Rogers discusses Agilent Seahorse technology and workflow advancements that enable simplified assessment of mitochondrial toxicity with high sensitivity and specificity. Points of discussion include the Mito Tox Index (MTI), a standardised parameter reflecting both the magnitude and mode of mitochondrial toxicity, as well as the applications of the Agilent Seahorse XF Mito Tox Assay solution, including examples with HepG2 cells and primary hepatocytes.
George W. Rogers, Ph.D.
Research Scientist, Expert Bioassay Solutions, Cell Analysis Division
Agilent Technologies, Inc.